The World Health Organization’s Director-General, Tedros Adhanom Ghebreyesus, says there is a critical need to find more COVID-19 treatments.

A malaria drug, a cancer drug and a drug used for people with diseases of the immune system are being tested for use in COVID-19 patients, the WHO says.

The World Health Organization says a clinical trial in 52 countries will study three anti-inflammatory drugs as potential treatments for COVID-19 patients.

“These therapies – artesunate, imatinib and infliximab – were selected by an independent expert panel for their potential in reducing the risk of death in hospitalised COVID-19 patients,” it said in a statement on the Solidarity PLUS trial.

The trial involves thousands of researchers at more than 600 hospitals, WHO director general Tedros Adhanom Ghebreyesus told a news briefing from Geneva.(SBS News)


Please enter your comment!
Please enter your name here